(*) CA Approval Date: 2019. 11.12.
(*) EU Approval Date: 2018. 11.15.
(*) USA Approval Date: 2019. 01.14.
>Previously Treated with Sorafenib
Company
Company Partner (CA, EU)
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 8
Patent>UpDate: 2019. 11.26.
TradeMark
TradeMark Web-Site